Fisher Scientific International Inc – ‘10-K’ for 12/31/05 – EX-23.01

On:  Tuesday, 2/21/06, at 4:29pm ET   ·   For:  12/31/05   ·   Accession #:  950135-6-1054   ·   File #:  1-10920

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K - Fisher Scientific International, Inc.   HTML   1.08M 
 2: EX-10.33    EX-10.33 - Second Amendment to Credit Agreement       16     56K 
 3: EX-10.37    EX-10.37 - First Amendment to Receivables Transfer    11     34K 
                          Agreement                                              
 4: EX-10.40    EX-10.40 - Waiver and Omnibus                          9     27K 
 5: EX-12.01    EX-12.01 - Computation of Ratios                       1      8K 
 6: EX-21.01    EX-21.01 - List of Subsidiaries of the Registrant      8     35K 
 7: EX-23.01    EX-23.01 Consent of Deloitte & Touche, LLP             1      8K 
 8: EX-31.01    EX-31.01 - SEC 302 Certification of CEO             HTML     12K 
 9: EX-31.02    EX-31.02 - SEC 302 Certification of CFO             HTML     12K 
10: EX-32.01    EX-32.01 - SEC 906 Certification of CEO             HTML      8K 
11: EX-32.02    EX-32.02 - SEC 906 Certification of CFO             HTML      8K 

EX-23.01   —   EX-23.01 Consent of Deloitte & Touche, LLP

EX-23.01
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                                   Exhibit 23.01

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No.      
333-124738 on Form S-3, Registration Statement No. 333-129654 on Form S-4, and  
Registration Statement Nos. 333-118239, 333-56979, 333-07391, 333-18563,        
333-28789, 333-109885, 333-68052, and 333-127050 on Form S-8 of our reports     
dated February 17, 2006, relating to the financial statements and financial     
statement schedule of Fisher Scientific International Inc. and management's     
report on the effectiveness of internal control over financial reporting,       
appearing in this Annual Report on Form 10-K of Fisher Scientific International 
Inc. for the year ended December 31, 2005.                                      

/s/ Deloitte & Touche LLP                                                       

New York, New York                                                              
February 17, 2006                                                               

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing		Date		Other Filings
Filed on:		2/21/06		4
		2/17/06		4
For Period End:		12/31/05
				List all Filings